Consolidated Statement Of Income

Modalis Therapeutics Corporation - Filing #7582738

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Consolidated statement of income
Statement of income
Operating expenses
Selling, general and administrative expenses
187,868,000 JPY
184,835,000 JPY
Operating expenses
Operating profit (loss)
-1,438,226,000 JPY
-677,519,000 JPY
Ordinary profit (loss)
-1,314,537,000 JPY
-661,924,000 JPY
Operating expenses
Research and development expenses
1,290,857,000 JPY
493,784,000 JPY
Non-operating income
Interest income
47,000 JPY
57,000 JPY
Other
303,000 JPY
235,000 JPY
Non-operating income
128,748,000 JPY
16,688,000 JPY
Extraordinary income
JPY
485,881,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
3,584,000 JPY
JPY
Non-operating expenses
5,059,000 JPY
1,092,000 JPY
Share issuance costs
817,000 JPY
1,092,000 JPY
Profit (loss) before income taxes
-1,314,537,000 JPY
-176,042,000 JPY
Income taxes - current
914,000 JPY
915,000 JPY
Extraordinary income
Income taxes - deferred
-5,624,000 JPY
4,414,000 JPY
Income taxes
-4,709,000 JPY
5,330,000 JPY
Profit (loss)
-1,309,827,000 JPY
-181,372,000 JPY
Profit (loss) attributable to owners of parent
-1,309,827,000 JPY
-181,372,000 JPY
Other comprehensive income
Foreign currency translation adjustment
28,880,000 JPY
6,488,000 JPY
Other comprehensive income
28,880,000 JPY
6,488,000 JPY
Profit attributable to
Comprehensive income
-1,280,946,000 JPY
-174,883,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,280,946,000 JPY
-174,883,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.